|
Browse contents:
Other resources:
|
||||||||

![]() |
![]() |
12th October, 2010
Milan, October
12th, 2010 - Meriva®
has been elected "Best New Product" of the year
by the judging panel of the European Outsourcing Awards.
This award goes to the company that has developed a market-leading product
that, through excellence in research, development and/or manufacturing,
has resulted in the launch of an exciting and innovative new offering in
the bio/pharmaceutical sector that combines innovative science or product
features in a way that demonstrates substantial benefits to patient
populations when compared with existing therapeutics available for that
disease condition.
Meriva®
is an Indena proprietary complex of curcumin (Curcuma longa L.)
that is capitalizing the basic tenets of the Phytosome®
strategy to improve the bioavailability. Recent studies have
demonstrated a dramatically enhanced bioavailability of Meriva®
of over 20-fold compared to a standardized curcumin extract and, in a
recent published long term clinical investigation, its safety and efficacy
in the treatment of inflammatory diseases has been confirmed.
According to the judges from the European Outsourcing Awards 2010:
"the most impressive attribute of this nomination was the
twenty-fold increase in bioavailability. Using humble turmeric in a
clinical trial to develop a new product is incredibly innovative, leading
to the development of a safe and effective product that can be delivered
at clinically realistic dosages - at a weight-to-weight price that's
comparable with standard 95% extracts".
Launched in 2005, in Madrid, the European Outsourcing Awards
recognizes significant developments in contract services and rewards
successful companies for their outstanding contributions and achievements
throughout the year. The awards were created to celebrate and recognize
excellence in R&D, marketing, business and technology across the
bio/pharmaceutical industry.
"We're very pleased to receive this award" said Christian
Artaria, Indena Marketing Director and Head of Functional Food
Development, at the prize gala ceremony "Indena's model
of identifying research and industrial collaborations ranging from R&D
Institutions to hospitals and private clinics early in the product
development cycle has again proven effective in shortening the time to
market with this exciting product".
*** *** ***
About curcumin
Curcumin is the yellow pigment of turmeric (Curcuma longa L.), the
most important spice of the Indian cuisine, and a major ingredient of
curry powders. In Asian Medicine, turmeric is used for the treatment of
inflammation and joint pain. In Western countries, it is mainly employed
as a food additive to color dairy products (cheese and yogurts), margarine
and canned food.
About Meriva®
Meriva®
is a patented complex of curcumin, a dietary phenolic, with soy
phosphatidyl choline. The two compounds form a non-covalent adduct in a
1:2 weight ratio, and two parts of microcrystalline cellulose are then
added to improve formulation, with an overall content of curcumin of 20%.
Meriva®
is already included as an ingredient in food supplements marketed in
USA and EU and available over the counter. To know more: www.phytosomes.info
About Indena
Indena is the world's leading company dedicated to the identification,
development and production of active principles derived from plants, for
use in the pharmaceutical, health food and cosmetics industries. Backed up
by over 85 years of botanical experience, the key to Indena's success
�� is its intense research activity. The company has more
than 150 primary patents and has published more than 700 scientific
studies. Indena employs more than 700 staff, including 10% dedicated to
full-time research activities carried out at Settala Research Center, near
Milan. Indena also co-operates with the world's most prestigious
universities and private research institutions. Headquartered in Milan,
Indena has five production sites and four international branches
throughout the world and manages distribution operations in more than 40
countries. The Company's experts communicate and interact constantly with
the major international regulatory authorities such as WHO, EMEA, and
ESCOP, and work with all the main pharmacopoeias. For further info about
Indena, visit www.indena.com
Indena Media Contacts
Cohn & Wolfe Milan
Laura Faravelli laura.faravelli@cohnwolfe.com
Lorenzo Petracco lorenzo.petracco@cohnwolfe.com
Tel.+39 02 202391


|
Terms & Conditions | Privacy Notice | Copyright©2012 Indena S.p.A. All right reserved Indena S.p.A. tel. +3902574961 fax +390257404620 P.IVA 04411780150 |
|